Dave Rosa
Chief Executive Officer
Replay available
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q2 2026 earnings conference call, held 2026-05-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ron McClurg
Chief Financial Officer
Jeremy Perlman
Analyst, Maxim Group
Gil Tells
Analyst, JonesTrading
Unidentified Participant
Q&A Participant
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Neuroone Medical Technologies Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.127 Good day, ladies and gentlemen, and welcome to NeuroOne Medical 00:00:05.127 -- 00:00:10.304 Technologies Corporation's second quarter fiscal 2026 financial results 00:00:10.304 -- 00:00:12.215 conference call. 00:00:12.215 -- 00:00:17.222 Today's call will be conducted by the company's chief executive officer, Dave Rosa, 00:00:17.222 -- 00:00:21.428 and Ron McClurg, the company's chief financial officer. 00:00:21.428 -- 00:00:25.974 Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference 00:00:25.974 -- 00:00:30.501 call will include forward-looking statements within the meaning of U.S. 00:00:30.501 -- 00:00:35.588 federal securities laws with respect to future operations, financial results, including 00:00:35.588 -- 00:00:40.815 events, trends, and performance, which are based on management's beliefs and assumptions 00:00:40.815 -- 00:00:43.058 as of today's call. 00:00:43.058 -- 00:00:47.643 Forward-looking statements may involve known and unknown risks, uncertainties, and other 00:00:47.643 -- 00:00:53.291 factors, which may cause actual results to differ materially from those expressed 00:00:53.291 -- 00:00:55.974 or implied by such statements. 00:00:55.974 -- 00:01:01.628 Senior 01's financial results press release and SEC filings for information regarding 00:01:01.628 -- 00:01:06.534 specific risks and uncertainties that could cause actual results to differ. 00:01:06.534 -- 00:01:11.799 Except as required by law, NeuroOne undertakes no obligation to update such forward-looking 00:01:11.799 -- 00:01:13.301 statements. 00:01:13.301 -- 00:01:15.703 With that, I will turn the call over to Mr. 00:01:15.703 -- 00:01:18.947 Dave Rosa, Chief Executive Officer of NeuroOne. 00:01:18.947 -- 00:01:21.029 Ple...